February 23, 2021
×
The country can scale in vaccine manufacturing, supply value chain, says Sanat Chattopadhyay, Executive Vice-President and President, Merck Manufacturing Division
Indian pharmaceutical companies, who have been playing a major role in global supply chains with supplies of generics, now have the potential to scale up the value chain, according to Sanat Chattopadhyay, Executive Vice-President and President, Merck Manufacturing Division.
Delivering his address at BioAsia 2021, a life-sciences and healthcare forum, being hosted in Hyderabad, he said: “In the last one year, a tsunami of changes has been unleashed, causing havoc on the global pharmaceutical industry. Our purpose at Merck is to improve access to life-saving therapeutics and vaccines across the world.”